Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

JANX

Janux Therapeutics, Inc.

CIK 0001817713 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$17.39
↑ 0.11 (0.64%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.06B
P/E Ratio
-10.36
EPS
-1.83
Dividend Yield
Not covered
52W Position
23%
Beta
1.11

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.15
P/S
44.30
EV/Revenue
43.14
ROE
-11.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 23%
$12.12$35.34

Latest Financials

2025-12-31 FY
Revenue
$10.00M
Net Income
-$113.63M
Total Assets
$1.00B
Free Cash Flow
-$83.28M

Recent news